Skip to main content
. 2019 Feb 19;10:203. doi: 10.3389/fimmu.2019.00203

Figure 2.

Figure 2

Transgenic mouse models of rheumatoid arthritis. Transgenic (Tg) mouse models of rheumatoid arthritis (RA) reported in the literature include mice expressing (i) RA-susceptible human leukocyte antigen (HLA) class II molecules, such as DRB1*0101 (DR1) or DRB1*0401 (DR4); (ii) human RA-associated autoantigens, such as type II collagen (CII), either complete or as mutated mouse collagen (MMC) containing the immunodominant epitope, and human cartilage glycoprotein-39 (HCgp-39); (iii) an autoantigen-specific T cell receptor (TCR) alone; or (iv) together with RA-susceptible HLA-DR molecules. Advantages are depicted in green color, limitations in red.